Pillstats
Labeler · US market

Vitruvias Therapeutics

Vitruvias Therapeutics is a US drug labeler with US FDA registrations covering 11 drug concepts (11 currently active) across 44 packages. It is currently the only active US supplier of 2 drugs. The company files with FDA under 2 name variants, merged into this profile.

Also files as: Vitruvias Therapeutics, Inc.

ACTIVE — US
openFDA · updated weekly
Labeler codes69680
Active drugs11
Registrations30 active / 30
Packages44
Sole supplier of2 drugs

Portfolio11 drugs · US

Every drug concept this labeler has US registrations for, by package count.

DrugTypeNDCsPackagesStatus
Bupropion Hydrochloride
tablet, extended release
rx28SUPPLYING
Cyanocobalamin
injection, solution
rx36SUPPLYING
Propafenone
capsule, extended release
rx36SUPPLYING
Thyroid
tablet
rx55SUPPLYING
Topiramate
capsule, extended release
rx55SUPPLYING
Memantine Hydrochloride
capsule, extended release
rx44SUPPLYING
Aminocaproic Acid
tablet
rx24SUPPLYING
Memantine Hydrochloride And Donepezil Hydrochloride
capsule, extended release
rx22SUPPLYING
Pramipexole Dihydrochloride
tablet, extended release
rx22SUPPLYING
Aminocaproic Acid
solution
rx11SUPPLYING
Icosapent Ethyl
capsule
rx11SUPPLYING